Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area proteases calpains'

Search results for: 'research area proteases calpains'

Items 21-30 of 60

Page
per page
  1. ONX-0914 (PR-957)
    A4011 ONX-0914 (PR-957)
     6 Citation
    Target: Proteasome
    Summary: Immunoproteasome inhibitor,potent and selective
      ≥29.03 mg/mL
  2. MG-115
    A2612 MG-115
     1 Citation
    Target: Proteasome
    Summary: Potent reversible proteasome inhibitor
      ≥23.08 mg/mL
  3. Carfilzomib (PR-171)
    A1933 Carfilzomib (PR-171)
     10 Citation
    Target: Proteasome
    Summary: Proteasome inhibitor, epoxomicin analog
      ≥35.99 mg/mL
  4. YO-01027 (Dibenzazepine, DBZ)
    A4018 YO-01027 (Dibenzazepine, DBZ)
     1 Citation
    Summary: γ-secretase inhibitor
      ≥23.17 mg/mL
  5. Vialinin A
    A4429 Vialinin A
    Target: Deubiquitinating enzymes (DUBs)|IL Receptors|CCL2
    Summary: USP/isopeptidase T (IsoT)/UCH-L1 DUB inhibitor
      Soluble in DMSO
  6. GI 254023X
    A4436 GI 254023X
     2 Citation
    Target: ADAMs
    Summary: Selective inhibitor of ADAM10 metalloprotease
      ≥42.6 mg/mL
  7. CA-074 Me
    A8239 CA-074 Me
     7 Citation
    Target: Cathepsins
    Summary: Cathepsin B inhibitor
      insoluble in H2O; ≥19.88 mg/mL
  8. Cathepsin S inhibitor
    A3284 Cathepsin S inhibitor
     1 Citation
    Target: Cathepsins
    Summary: Blocks MHCII antigen presentation
      ≥24.25 mg/mL
  9. Bestatin
    A2575 Bestatin
    Target: Aminopeptidases
    Summary: Aminopeptidase inhibitor
      insoluble in H2O; insoluble in EtOH; ≥12.34 mg/mL
  10. AT13387
    A4056 AT13387
    Target: HSP90
    Summary: Hsp90 inhibitor
      insoluble in H2O; ≥13.25 mg/mL

Items 21-30 of 60

Page
per page
Shop By
Now Shopping by
  1. Category Signaling Pathways Remove This Item
  2. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Proteases 46item
  2. Metabolism 9item
  3. DNA Damage/DNA Repair 1 item
  4. Microbiology & Virology 7item
  5. Ubiquitination/ Proteasome 14item
  6. Angiogenesis 1 item
  7. Neuroscience 1 item
Reversibility
  1. Reversible 9item
  2. Irreversible 6item
Target
  1. Proteasome 9item
  2. Cathepsins 11item
  3. MMP 3item
  4. Thymidylate Synthase 1 item
  5. Deubiquitinating enzymes (DUBs) 1 item
  6. Aminopeptidases 2item
  7. HSP90 4item
  8. Renin 1 item
  9. HIV proteases 1 item
  10. Pepsins 1 item
  11. Calpains 5item
  12. Ubiquitin-specific proteases 1 item
  13. HCV Proteases 2item
  14. Trypsins 1 item
  15. Trypsin 1 item
  16. Chymotrypsin 1 item
  17. Kallikrein 1 item
  18. Trypsinogen 1 item
  19. HIV-1 gp120 1 item
  20. Fatty-acid-binding proteins (FABPs) 1 item
  21. 20S proteasomal chymotrypsin 1 item
  22. Geranylgeranyltransferase I 1 item
  23. Farnesyltransferase 1 item
  24. IL Receptors 1 item
  25. CCL2 1 item
  26. Papains 1 item
  27. DPP-4 3item
  28. ADAMs 1 item
  29. PAR 1 item
  30. Elastases 1 item
Reported Experiments
  1. Animal Experiments 57item
  2. Cell Experiments 39item
Related Disease
  1. Acute Lung Injury 1 item
  2. Breast Cancer 8item
  3. Cancer 26item
  4. Colon Cancer 3item
  5. Colon Carcinoma 1 item
  6. Colorectal Cancer 1 item
  7. Diabetes 3item
  8. Glioma 1 item
  9. HCV 1 item
  10. Hepatitis C 1 item
  11. HIV 1 item
  12. HIV Infections 1 item
  13. Inflammatory Diseases 1 item
  14. Leukemia 1 item
  15. Lung Cancer 1 item
  16. Lymphoma 1 item
  17. Mantle Cell Lymphoma 1 item
  18. Melanoma 3item
  19. Multiple Myeloma 4item
  20. Myeloma 2item
  21. Neuroblastoma 1 item
  22. Non-small Cell Lung Cancer 3item
  23. Osteoporosis 1 item
  24. Ovarian Cancer 3item
  25. Pancreatic Cancer 2item
  26. Prostate Cancer 2item
  27. Psoriasis 1 item
  28. Renal Cell Carcinoma 1 item
  29. Rheumatoid Arthritis 2item
  30. Squamous Cell Carcinoma 1 item
  31. Type 2 Diabetes 1 item